Keiko Wanaka

746 total citations
55 papers, 583 citations indexed

About

Keiko Wanaka is a scholar working on Cancer Research, Genetics and Hematology. According to data from OpenAlex, Keiko Wanaka has authored 55 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cancer Research, 21 papers in Genetics and 20 papers in Hematology. Recurrent topics in Keiko Wanaka's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (21 papers), Protease and Inhibitor Mechanisms (20 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (15 papers). Keiko Wanaka is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (21 papers), Protease and Inhibitor Mechanisms (20 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (15 papers). Keiko Wanaka collaborates with scholars based in Japan, United States and United Kingdom. Keiko Wanaka's co-authors include Akiko Hijikata‐Okunomiya, Shosuke Okamoto, U Okamoto, Yuko Tsuda, Yoshio Okada, Takefumi Matsuo, Naoki Teno, Yoshio Okada, Keigo Gohda and Hidetomo Nakamoto and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Leukemia and Biopolymers.

In The Last Decade

Keiko Wanaka

54 papers receiving 568 citations

Peers

Keiko Wanaka

HEMAT

SURGE

GENET

ML Rand Canada

James McKenney United States

G Blaskó Hungary

Mustafa Altınbaş Türkiye

H. J. Reimers Canada

Chi‐Jen Chang Taiwan

I. A. G. Reilly United Kingdom

Katsuhiro Fukutake Japan

Kōjirō Yasunaga Japan

Colin Germond Canada

ML Rand Canada

Keiko Wanaka

314 ×1.4

HEMAT

53 ×0.3

78 ×0.6

87 ×0.6

SURGE

75 ×0.7

GENET

Citations per year, relative to Keiko Wanaka Keiko Wanaka (= 1×) peers ML Rand

Countries citing papers authored by Keiko Wanaka

Since Specialization

Citations

This map shows the geographic impact of Keiko Wanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiko Wanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiko Wanaka more than expected).

Fields of papers citing papers by Keiko Wanaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiko Wanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiko Wanaka. The network helps show where Keiko Wanaka may publish in the future.

Co-authorship network of co-authors of Keiko Wanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Keiko Wanaka. A scholar is included among the top collaborators of Keiko Wanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiko Wanaka. Keiko Wanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Teno, Naoki, Keigo Gohda, Yukiko Yamashita, et al.. (2016). Plasmin inhibitors with hydrophobic amino acid-based linker between hydantoin moiety and benzimidazole scaffold enhance inhibitory activity. Bioorganic & Medicinal Chemistry Letters. 26(9). 2259–2261. 8 indexed citations

Wanaka, Keiko, et al.. (2014). Novel HIT antibody detection method using Sonoclot® coagulation analyzer. Thrombosis Research. 135(1). 127–129. 1 indexed citations

Teno, Naoki, Keigo Gohda, Keiko Wanaka, et al.. (2014). Pyrrolopyrimidine-inhibitors with hydantoin moiety as spacer can explore P4/S4 interaction on plasmin. Bioorganic & Medicinal Chemistry. 22(7). 2339–2352. 10 indexed citations

Ishihara, Makoto, Chiemi Nishida, Yoshihiko Tashiro, et al.. (2011). Plasmin inhibitor reduces T-cell lymphoid tumor growth by suppressing matrix metalloproteinase-9-dependent CD11b+/F4/80+ myeloid cell recruitment. Leukemia. 26(2). 332–339. 22 indexed citations

Teno, Naoki, Keigo Gohda, Keiko Wanaka, Takuya Sueda, & Yuko Tsuda. (2011). Identification of novel plasmin inhibitors possessing nitrile moiety as warhead. Bioorganic & Medicinal Chemistry Letters. 21(21). 6305–6309. 9 indexed citations

Matsuo, Takefumi, et al.. (2007). Heparin-induced Thrombocytopenia in a Uremic Patient Requiring Hemodialysis. Clinical and Applied Thrombosis/Hemostasis. 13(2). 182–187. 20 indexed citations

Matsuo, Takefumi, Hiroko Kobayashi, Miyako Matsuo, et al.. (2006). Frequency of Anti-Heparin-PF4 Complex Antibodies (HIT Antibodies) in Uremic Patients on Chronic Intermittent Hemodialysis. Pathophysiology of Haemostasis and Thrombosis. 35(6). 445–450. 22 indexed citations

Nakamoto, Hidetomo, et al.. (2005). Role of platelet factor 4–heparin complex antibody (HIT antibody) in the pathogenesis of thrombotic episodes in patients on hemodialysis. Hemodialysis International. 9(s4). S2–7. 21 indexed citations

Tomoo, Koji, Kazumi Satoh, Yuko Tsuda, et al.. (2001). Binding Diversity of a Noncovalent-Type Low-Molecular-Weight Serine Protease Inhibitor and Function of a Catalytic Water Molecule: X-Ray Crystal Structure of PKSI-527-Inhibited Trypsin. The Journal of Biochemistry. 129(3). 455–460. 4 indexed citations

10.

Okada, Yoshio, et al.. (2000). Development of Potent and Selective Plasmin and Plasma Kallikrein Inhibitors and Studies on the Structure-Activity Relationship.. Chemical and Pharmaceutical Bulletin. 48(12). 1964–1972. 29 indexed citations

11.

Okada, Yoshio, et al.. (2000). Development of Plasmin-Selective Inhibitors and Studies of Their Structure-Activity Relationship.. Chemical and Pharmaceutical Bulletin. 48(2). 184–193. 10 indexed citations

12.

Wanaka, Keiko, et al.. (1999). Amino Acids and Peptides. LIII. Synthesis and Biological Activities of Some Pseudo-Peptide Analogs of PKSI-527, a Plasma Kallikrein Selective Inhibitor. The Importance of the Peptide Backbone.. Chemical and Pharmaceutical Bulletin. 47(8). 1141–1144. 7 indexed citations

13.

Tsuda, Yuko, et al.. (1998). Design of Plasma Kallikrein Inhibitors: Functional and Structural Requirements of Plasma Kallikrein Inhibitors.. Chemical and Pharmaceutical Bulletin. 46(3). 452–457. 4 indexed citations

14.

Okamoto, Shosuke, Akiko Hijikata‐Okunomiya, Keiko Wanaka, Yoshio Okada, & U Okamoto. (1997). Enzyme-Controlling Medicines: Introduction. Seminars in Thrombosis and Hemostasis. 23(6). 493–501. 87 indexed citations

15.

Wanaka, Keiko, et al.. (1996). Use of an active center-directed plasmin inhibitor elucidates the multiplicity of plasmin actions. Thrombosis Research. 82(1). 79–86. 7 indexed citations

16.

Nakamura, Makoto, T. Ishida, Hiroaki Taguchi, et al.. (1995). Design of Noncovalent Trypsin Inhibitor Based on the X-Ray Crystal Structure of the Complex. Biochemical and Biophysical Research Communications. 213(2). 583–587. 4 indexed citations

17.

Teno, Naoki, et al.. (1991). Development of Selective Inhibitors against Plasma Kallikrein.. Chemical and Pharmaceutical Bulletin. 39(11). 2930–2936. 6 indexed citations

18.

Teno, Naoki, et al.. (1991). Development of Active Center-Directed Inhibitors against Plasmin.. Chemical and Pharmaceutical Bulletin. 39(9). 2340–2346. 16 indexed citations

19.

Okamoto, Shosuke, et al.. (1989). Highly Selective Synthetic Inhibitors with Regard to Plasma-Kallikrein Activities. Advances in experimental medicine and biology. 247B. 29–34. 6 indexed citations

20.

Okamoto, Shosuke, U Okamoto, Akiko Hijikata‐Okunomiya, Keiko Wanaka, & Yasunori Okada. (1988). Recent studies of the synthetic selective inhibitors; with special reference to non-plasmin fibrinolytic enzyme, plasmin and plasma-kallikrein. Thrombosis Research. 49. 131–141. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact